Baader Bank Aktiengesellschaft acquired a new stake in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 2,089 shares of the company’s stock, valued at approximately $205,000.
Other large investors have also made changes to their positions in the company. Redhawk Wealth Advisors Inc. increased its holdings in Cardinal Health by 145.7% during the 2nd quarter. Redhawk Wealth Advisors Inc. now owns 5,180 shares of the company’s stock valued at $509,000 after purchasing an additional 3,072 shares in the last quarter. Tsfg LLC lifted its position in shares of Cardinal Health by 14.4% during the second quarter. Tsfg LLC now owns 9,208 shares of the company’s stock worth $905,000 after purchasing an additional 1,161 shares in the last quarter. ORG Partners LLC increased its holdings in shares of Cardinal Health by 899.6% in the second quarter. ORG Partners LLC now owns 5,308 shares of the company’s stock valued at $519,000 after purchasing an additional 4,777 shares in the last quarter. Diversified Trust Co raised its position in Cardinal Health by 3.7% in the 2nd quarter. Diversified Trust Co now owns 24,591 shares of the company’s stock worth $2,418,000 after purchasing an additional 871 shares during the last quarter. Finally, Wedmont Private Capital lifted its holdings in Cardinal Health by 9.8% during the 2nd quarter. Wedmont Private Capital now owns 3,806 shares of the company’s stock worth $358,000 after buying an additional 339 shares in the last quarter. Institutional investors own 87.17% of the company’s stock.
Cardinal Health Price Performance
Shares of CAH opened at $107.79 on Friday. The firm has a 50-day moving average of $99.15 and a 200-day moving average of $103.21. The company has a market cap of $26.25 billion, a PE ratio of 47.96, a price-to-earnings-growth ratio of 1.14 and a beta of 0.61. Cardinal Health, Inc. has a one year low of $85.11 and a one year high of $116.04.
Wall Street Analysts Forecast Growth
Several research firms have recently commented on CAH. Citigroup lowered their target price on Cardinal Health from $115.00 to $107.00 and set a “neutral” rating for the company in a research note on Friday, July 19th. Wells Fargo & Company increased their price objective on shares of Cardinal Health from $95.00 to $101.00 and gave the company an “underweight” rating in a report on Thursday. UBS Group upped their target price on shares of Cardinal Health from $120.00 to $125.00 and gave the company a “buy” rating in a research report on Thursday. Robert W. Baird boosted their target price on Cardinal Health from $130.00 to $137.00 and gave the stock an “outperform” rating in a research report on Thursday. Finally, Argus lowered their price target on Cardinal Health from $120.00 to $115.00 and set a “buy” rating for the company in a report on Wednesday, May 15th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat.com, Cardinal Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $113.25.
Get Our Latest Research Report on CAH
Cardinal Health Company Profile
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Read More
- Five stocks we like better than Cardinal Health
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Deere Rebounds on Earnings Beat, But Uphill Battle Remains
- What is the Nikkei 225 index?
- Mutual Funds vs Hedge Funds: What’s the Difference?
- Energy and Oil Stocks Explained
- 3 Beaten-Down Tech Stocks That Shouldn’t Be Overlooked
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.